Literature DB >> 25902915

Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.

Zlatko Marušić1, Marija Buljan2, Klaus J Busam3.   

Abstract

BACKGROUND: Multiple BAP1 negative melanocytic neoplasms are a hallmark of familial cancer susceptibility syndrome caused by BAP1 germline mutation. The syndrome is characterized by increased incidence of renal cell carcinoma, mesothelioma, cholangiocarcinoma, cutaneous and uveal melanoma and some other neoplasms.
METHODS: We report histomorphologic characteristics of six cutaneous melanocytic neoplasms with loss of BAP1 expression in two members of a family with BAP1-associated cancer susceptibility syndrome.
RESULTS: The neoplasms were dermal melanocytic nevi characterized by a proliferation of large epithelioid (spitzoid) melanocytes, and adipocytic metaplasia. Nuclear pseudoinclusions and multinucleated melanocytes were present in most neoplasms. In two of the cases, a nodular melanoma was found associated with a dermal nevus. None of the melanomas recurred or metastasized after 6 and 3 years of follow up.
CONCLUSIONS: We report two new cases of melanoma arising in a BAP1-deficient melanocytic nevus in the setting of familial tumor predisposition syndrome. Adipocytic metaplasia and nuclear pseudoinclusions may be additional morphologic clues to a BAP1-deficient nevus. It remains to be seen whether these features are more common in familial than sporadic lesions.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BAP1; cancer; hereditary; melanocytic; neoplasm

Mesh:

Substances:

Year:  2015        PMID: 25902915     DOI: 10.1111/cup.12493

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  6 in total

1.  Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Michael T Tetzlaff; Jonathan L Curry; Guilin Tang; Zied Abdullaev; Svetlana D Pack; Doina Ivan; Victor G Prieto; Carlos A Torres-Cabala
Journal:  Am J Dermatopathol       Date:  2019-03       Impact factor: 1.533

2.  Novel insights into the BAP1-inactivated melanocytic tumor.

Authors:  Michele Donati; Petr Martinek; Petr Steiner; Petr Grossmann; Tomas Vanecek; Liubov Kastnerova; Isabel Kolm; Martina Baneckova; Pietro Donati; Irina Kletskaya; Antonina Kalmykova; Josef Feit; Petr Blasch; Diana Szilagyi; Alfonso Baldi; Paolo Persichetti; Anna Crescenzi; Michal Michal; Dmitry V Kazakov
Journal:  Mod Pathol       Date:  2021-12-02       Impact factor: 7.842

Review 3.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

4.  A population-based analysis of germline BAP1 mutations in melanoma.

Authors:  Sally J O'Shea; Carla Daniela Robles-Espinoza; Lauren McLellan; Jeanine Harrigan; Xavier Jacq; James Hewinson; Vivek Iyer; Will Merchant; Faye Elliott; Mark Harland; D Timothy Bishop; Julia A Newton-Bishop; David J Adams
Journal:  Hum Mol Genet       Date:  2017-02-15       Impact factor: 6.150

5.  BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.

Authors:  Bianca Costa Soares de Sá; Mariana Petaccia de Macedo; Giovana Tardin Torrezan; Juliana Casagrande Tavoloni Braga; Felipe Fidalgo; Luciana Facure Moredo; Rute Lellis; João Pereira Duprat; Dirce Maria Carraro
Journal:  BMC Cancer       Date:  2019-11-09       Impact factor: 4.430

6.  Histopathology of melanocytic lesions in a family with an inherited BAP1 mutation.

Authors:  Sally J O'Shea; Angana Mitra; Jennifer L Graham; Ruth Charlton; Julian Adlard; Will Merchant; Julia A Newton-Bishop
Journal:  J Cutan Pathol       Date:  2015-10-12       Impact factor: 1.587

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.